Chief Scientific Officer of Homology Medicines, Inc. (U.S.: Nasdaq:FIXX), Seymour Albert, sells 1,661 shares worth $6,279
According to Homology Medicines, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jan 12 04:05 PM, company Chief Scientific Officer, Seymour Albert disclosed selling 1,661 shares at a cost of $3.78. At the time of this transaction (Jan 05), this trade was worth $6,279 in total. As of Jan 05, Seymour Albert now owns 131,646 shares in total worth about $483,799.05.
For the last few recent trades made by Homology Medicines, Inc. (U.S.: Nasdaq:FIXX) Chief Scientific Officer, Seymour Albert, we have the following information:
- SEC Form 4 filing: Jan 06: Sold 9,897 shares at the rate of $12.06 per share. Total worth of this trade was $119,395. Total number of shares owned as of Jan 06 were 134,120
- SEC Form 4 filing: Jan 07: Sold 5,103 shares at the rate of $12.05 per share. Total worth of this trade was $61,469. Total number of shares owned as of Jan 07 were 129,017
- SEC Form 4 filing: Jan 05: Sold 10,000 shares at the rate of $11.44 per share. Total worth of this trade was $114,422. Total number of shares owned as of Jan 05 were 144,017
Posted by
George Daniels
on Thursday January 13 2022, 1:28 PM EST.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
